Skip to content

Evaluation of the Efficacy of Somatosensory Rehabilitation of Pain by Vibrotactile Stimulation on Static Mechanical Allodynia

Pilot Study to Evaluate the Effectiveness of Somatosensory Rehabilitation of Pain by Vibrotactile Stimulation on Static Mechanical Allodynia of Less Than Three Months Duration

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02571010
Acronym
RESISTAL
Enrollment
17
Registered
2015-10-08
Start date
2015-10-31
Completion date
2019-05-02
Last updated
2020-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allodynia

Keywords

static mechanical allodynia, somatosensory rehabilitation, vibrotactile stimulation

Brief summary

This study aims to demonstrate that somatosensory rehabilitation of pain associated with static mechanical allodynia has superior efficacy over placebo treatment as well as over spontaneous changes.

Detailed description

This is a monocenter study. 45 patients will be enrolled in the study, allocated by randomization in 3 arms of 15 patients each. During the 38 week duration of the study, enrolled patients will be assessed at: * initial evaluation (first week of the study), * intermediary evaluation for every week and every modification of intensity of pain, * final evaluation at 10 weeks, * follow-up evaluation at 6 months.

Interventions

OTHERStandard Medical treatment

Standard treatment with drugs and usual rehabilitation

Rehabilitation by vibrotactile stimulation at medical center

DEVICESham Stimulation with Vibradol device switched off

Sham Rehabilitation at medical center but with Vibradol device switched off

Sponsors

Hôpitaux Universitaires Paris Ile-de-Franc Ouest
CollaboratorOTHER
CRRF La Châtaigneraie
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligibility Criteria 1. Male or female patients aged ≥18 years; 2. Static mechanical allodynia for less than 3 months, whatever its etiology and topography; 3. Probable peripheral or central neuropathic pain or defined according to the IASP criteria; 4. Neuropathic pain diagnostic questionnaire DN4 score ≥ 4/10; 5. Chronic pain with average intensity ≥ 4/10; 6. Analgesic treatment unchanged within 15 days prior to screening, and not planned to be modified during the study; 7. Patient who can attend follow-up visits during the study; 8. Patient affiliated to a health insurance plan or entitled; 9. Patient must be able to give informed consent in accordance with ICH GCP guidelines and local legislation and/or regulations.

Exclusion criteria

1. Patient with neuralgia (spontaneous pain) with or without allodynia; 2. Patient not able to participate actively to the rehabilitation exercises for physical reason, cognitive reason (ability to understand instructions) or behavioural reason (e.g. addiction...); 3. Patient with complex regional pain syndrome (type I); 4. Patients for whom cares cannot avoid any touch with allodynia area; 5. Patient previously treated by a transcutaneous electrical nerve stimulation (TENS); 6. Prior treatment by somatosensory rehabilitation; 7. Duration of stay in the medical center \< 11 weeks; 8. Patient with cognitive disorder; 9. Allodynia area of the patient presenting with conditions not recommended for vibrotactile stimulation: wound, unhealed nerve suture, recent skin transplantation, fragile organ such as eye.

Design outcomes

Primary

MeasureTime frameDescription
Change of baseline in reduction of surface of allodynia areaAt baseline, each week during the 10 week treatment period and at 6 monthsEvaluate by the 15 g mono filament (Allodynographie) the reduction of surface of allodynia area

Secondary

MeasureTime frameDescription
Change of baseline in reduction of painAt baseline, at each week, at 10 weeks and at 6 monthsReduction of pain will be evaluated by QDSA questionnaire.
Change of baseline in reduction of allodynia intensityAt baseline, at each week, at 10 weeks and at 6 monthsReduction of allodynia intensity will be measured with the method with the colors
Change of baseline of patient's satisfaction with regard to received careAt baseline, at each week, at 10 weeks and at 6 monthsPatient's satisfaction with regard to pain relief will be evaluated by VAS
Analgesics consumptionAt 6 monthsAmount of analgesic drugs
Afterglow effectAt 6 monthsAn evaluation of static mechanical allodynia in surface and intensity at 6 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026